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Abstract
CD4
+ T cell loss is central to HIV pathogenesis. In the initial weeks post-infection, the great majority of dying cells are
uninfected CD4
+ T cells. We previously showed that the 3S motif of HIV-1 gp41 induces surface expression of NKp44L, a
cellular ligand for an activating NK receptor, on uninfected bystander CD4
+ T cells, rendering them susceptible to
autologous NK killing. However, the mechanism of the 3S mediated NKp44L surface expression on CD4
+ T cells remains
unknown. Here, using immunoprecipitation, ELISA and blocking antibodies, we demonstrate that the 3S motif of HIV-1 gp41
binds to gC1qR on CD4
+ T cells. We also show that the 3S peptide and two endogenous gC1qR ligands, C1q and HK, each
trigger the translocation of pre-existing NKp44L molecules through a signaling cascade that involves sequential activation
of PI3K, NADPH oxidase and p190 RhoGAP, and TC10 inactivation. The involvement of PI3K and NADPH oxidase derives
from 2D PAGE experiments and the use of PIP3 and H2O2 as well as small molecule inhibitors to respectively induce and
inhibit NKp44L surface expression. Using plasmid encoding wild type or mutated form of p190 RhoGAP, we show that 3S
mediated NKp44L surface expression on CD4
+ T cells is dependent on p190 RhoGAP. Finally, the role of TC10 in NKp44L
surface induction was demonstrated by measuring Rho protein activity following 3S stimulation and using RNA
interference. Thus, our results identify gC1qR as a new receptor of HIV-gp41 and demonstrate the signaling cascade it
triggers. These findings identify potential mechanisms that new therapeutic strategies could use to prevent the CD4
+ T cell
depletion during HIV infection and provide further evidence of a detrimental role played by NK cells in CD4
+ T cell depletion
during HIV-1 infection.
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Introduction
CD4 cell depletion and the resulting immune dysfunction are
hallmarks of HIV-1 infection. Although this phenomenon appears
to be the principal component of HIV disease, its underlying
mechanisms remain controversial. The CD4
+ T cell loss observed
during the chronic phase of infection was initially thought to result
from the death of productively infected CD4
+ T cells, due to the
cytopathic effects of viral replication and cytotoxic CD8-mediated
killing [1,2]. Several studies have demonstrated, however, that
most dying cells are uninfected and thus suggest that the death of
uninfected bystander CD4
+ T cells plays a major role in CD4
depletion [1,3]. Since then, numerous studies have strengthened
this hypothesis. Several HIV-1 proteins, including gp120, Tat, and
Nef, activate a variety of disparate pathways to initiate apoptosis in
uninfected cells [4]. An alternative proposal is that the high level of
immune activation in HIV-infected individuals may cause the
killing of uninfected CD4
+ T cells, by activation-induced cell death
(AICD) through Fas [5]. The importance of CD4
+ T cell
preservation in this disease is highlighted by findings in African
green monkeys infected with SIVagm: despite high viral
replication, their CD4
+ T cell counts remain normal, and they
do not develop AIDS [6].
Increasing evidence suggests that NK cells are involved in CD4
+
T cell depletion. We have shown that after HIV infection a
significant fraction of the CD4-cell subset expresses NKp44L, an
activator ligand of the natural cytotoxicity receptor NKp44 [7].
NKp44L expression renders CD4
+ T cells sensitive to autologous
NK lysis. This expression is strongly correlated with both the
decline in the CD4 cell count and the increase in viral load [8].
The role of NKp44L in CD4
+ T cell depletion was confirmed
in vivo in an SHIV-infected macaque model [9]. Ward et al. [10]
demonstrated that the ligand for NKp44 is expressed only on
uninfected bystander CD4
+ T cells. More recently, we showed that
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evasion, mediates intracellular retention of NKp44L in HIV-
infected CD4
+ T cells [11]. These results suggest that HIV-1 has
acquired the ability to use NK cells to disarm the host immune
system by selectively triggering the death of uninfected CD4
+ T
cells.
We have previously showed that a specific motif of HIV-gp41,
which is called 3S and is highly conserved in HIV-1 isolates, plays
a pivotal role in NKp44L expression [8]. HIV-gp41 protein is a
subunit of the Env complex protein and is essential for HIV entry
into target cells [12]. The interaction of gp120 with the target cell
surface induces conformational changes in the gp120-gp41
complex that expose the gp41 molecules and appear to promote
fusion between the viral and cellular membranes [13]. During this
process, several gp41 motifs become accessible to the surface,
including the 3S motif located between residues 618–623 [8,14].
Studies in a macaque model have confirmed the important role of
this 3S motif in HIV-1 pathogenicity and showed that immuni-
zation with the 3S motif prevents NKp44L expression and CD4
+
T cell depletion following SHIV infection [15].
Interestingly, it has been reported that the HIV-gp41 motif
located between residues 601–620 binds to the complement
component 1q (C1q) and then activates the classic complement
cascade in the absence of antibody [16]. In addition, the gp41
epitope between residues 615–635, which includes the 3S motif,
interacts with complement factor H, a negative regulator of the
complement cascade that can induce virus opsonization [17,18].
Its simultaneous triggering of the complement cascade pathway
and binding to one of its negative regulators may make HIV-1
gp41 crucial for viral spread and for T cell susceptibility to HIV
infection [17,19].
In this study, we sought to identify the receptor of the HIV-gp41
3S motif on CD4
+ T cells and examined the signaling pathway
leading to NKp44L surface expression. We discovered that the 3S
motif binds to gC1qR, a receptor for the globular domain of C1q,
on CD4
+ T cells. This interaction activates successively the PI3K,
the NADPH oxidase, and the p190A RhoGAP proteins.
Activation of this signaling cascade induces the translocation of
pre-existing NKp44L molecules from the cytoplasm to the plasma
membrane of CD4
+ T cells via a TC10-dependent mechanism.
Results
The 3S motif of HIV-gp41 stimulates ROS production by
NADPH oxidase
We investigated the signaling cascade triggered by the 3S
peptide to induce NKp44L cell-surface expression on CD4
+ T
cells. To identify the proteins involved in this cascade, we
subjected total protein extracts of U2 cells to a standard two-
dimensional polyacrylamide gel electrophoresis (2D PAGE), in the
presence or absence of 3S peptide. Proteins differentially expressed
by more than twofold were identified by mass spectrometry
(MALDI-TOF). Table 1 summarizes in detail the analytic data for
each identified spot. The up-regulation of peroxiredoxin and the
presence of oxidized forms of GADPH, characterized by their low
isoelectric points, indicated the presence of hydrogen peroxide
(H202) in cells incubated with the 3S peptide [20].
Author Summary
HIV infected individuals suffer from a loss of CD4
+
lymphocytes. Initially, dying CD4
+ lymphocytes are mainly
infected ones. Afterward, the great majority of dying CD4
+
lymphocytes are uninfected. The cause of uninfected CD4
+
lymphocyte death during HIV infection is still under
debate. We previously showed that one of the HIV-1
envelop proteins, gp41, induces the expression of a stress
molecule called NKp44L on the surface of uninfected CD4
+
lymphocytes. Uninfected CD4
+ lymphocytes expressing
NKp44L are killed, in vitro and in vivo, by cells of the
immune system called NK cells. In this report, we study the
CD4
+ lymphocyte’s proteins involved in the expression of
NKp44L. To do so, we used several techniques to identify
interacting or differentially expressed proteins and to
inhibit or monitor enzymes activity. We also induce
NKp44L using the product of some of the proteins
involved in NKp44L expression. We found that HIV-1
gp41 binds to its receptor gC1qR on CD4
+ lymphocytes.
This interaction respectively activates the PI3K, the NADPH
oxidase and p190 RhoGAP which inactivates TC10. Using
the obtained data we build a model of the protein cascade
involved in NKp44L surface expression.
Table 1. List of proteins differentially expressed at least two-fold in U2 cells incubated for 4 h in presence of the 3S peptide.
Name Mw (KDa) pI error (ppm) score Expression
Ran specific GTPase activating protein 23.467 5.19 23 81 Underrexpressed
Importin Subunit beta-1 98.42 4.68 41 36 Underrexpressed
Peroxiredoxin 22.3 8.27 42 71 Overexpressed
Heterogenous nuclear ribo-nucleoprotein F 45.99 5.38 29 91 Overexpressed
Mannose-6-phosphate receptor binding protein-1 47.189 5.3 30 141 Overexpressed
GTP binding nuclear protein Ran 24.579 7.01 30 100 Overexpressed
Lisoaspartate (D-aspartate) 0 methyltransferase 24.806 6.7 9 93 Overexpressed
Proteasome subunit alpha Type-2 25.496 6.92 44 127 Overexpressed
calcyclin binding protein+Adenylate kinase isoenzyme -2, mitochondria 26.308, 26.689 8.28, 7.67 7, 5 160 Overexpressed
Spermidine synthase 34 5.3 19 165 Overexpressed
G3PDH+ 60S acidic ribosomal protein 60 36, 34 8.6, 5.6 21, 23 193 Overexpressed
G3PDH 36 8.6 12 80 Overexpressed
IF2A eukaryote translational initiation factor-2 36.4 5.02 16 84 Overexpressed
doi:10.1371/journal.ppat.1000975.t001
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mediated signaling, the intracellular concentration of H202 was
measured with DCFH-DA in purified CD4
+ T cells incubated
with or without the 3S peptide. Phorbol 12-myristate 13 acetate
(PMA), which induces H202 production, was used as a positive
control [21]. As Figure 1A shows, incubation with 20 mg/ml 3S
peptide induced an increase in the intracellular H202 concentra-
tion, similar to the level observed following PMA incubation.
To confirm the role played by H202 in NKp44L surface
expression, we incubated CD4
+ T cells with H202 and detected
similar levels of NKp44L surface expression on the CD4
+ T cells
treated with 100 mMH 202 and with 5 mg/ml 3S peptide
(Figure 1B). Next, assessment of the effect of N-acetyl L cysteine
(NAC), an antioxidant, on NKp44L surface expression showed
that 10 mM NAC completely abolished this surface expression on
purified CD4
+ T cells treated with 5 mg/ml 3S peptide (Figure 1C).
To confirm a previous report that H202 synthesis in lymphocytes
depends on NADPH oxidase activation [20], we treated cells with
diphenyleneiodonium chloride (DPI), an NADPH oxidase inhib-
itor, and observed a drastic decrease in 3S-mediated NKp44L cell-
surface expression (Figure 1D).
Together, these data indicate that NADPH oxidase may play a
key role in the signaling pathway induced by the 3S peptide that
leads to NKp44L surface expression and showed that H202 is
sufficient to induce this expression.
The 3S motif of HIV-gp41 activates p190 RhoGAP
Next, we sought to identify the molecules involved downstream
of H202 production in 3S-mediated signal transduction. Nimnual
et al. [22] described the redox-dependent activation of p190
RhoGAP: H202 produced by NADPH oxidase inhibits the low
molecular weight protein tyrosine phosphatase (LMW-PTP),
which in turn inhibits p190 RhoGAP A (p190A) activity by
dephosphorylating it. To determine whether p190A functions as a
downstream effector of H202 in NKp44L surface expression, we
used purified CD4
+ T cells transfected with plasmid containing
either wild-type p190 RhoGAP A (p190 WT) or its dominant
negative form (p190 DN). Remarkably, transient transfection with
p190 WT was sufficient to induce NKp44L cell-surface expression,
while overexpression of p190 DN had no effect (Figure 2A).
As previously reported, p190A stimulates the GTPase activity of
some Rho GTPases, including RhoA and its isoforms RhoB-C as
well as TC10, and therefore promotes their GDP-bound form
[23,24]. Accordingly, we used a commercial ELISA-based assay to
investigate RhoA activity in the lysate of purified CD4
+ T cells in
the presence of the 3S peptide. As expected, after 3S peptide
treatment, RhoA activity decreased transiently by twofold, before
returning to its initial level (Figure 2B).
NKp44L surface expression is TC10-dependent
TC10/RhoQ is a member of the Rho GTPase family and, like
other members of this family, it cycles between an inactive GDP-
bound state and an active GTP-bound form. Interestingly, TC10
is mainly located on vesicles that are visible throughout the
cytoplasm [25]. To determine whether TC10 plays a role in 3S-
mediated NKp44L surface expression, TC10 was knocked down
by RNA interference (RNAi) in purified CD4
+ T cells before 3S
peptide stimulation. The down-modulation of TC10 in the
presence of specific siRNAs was confirmed by western blot
(Figure 2C). As Figure 2D shows, two specific TC10 siRNAs
strongly reduced NKp44L cell-surface expression after incubation
with the 3S peptide, while control siRNA had no effect.
Interestingly, the level of NKp44L down-regulation by specific
TC10 siRNAs correlated with their ability to down-modulate
TC10. This result indicates that TC10 is required for NKp44L
cell-surface expression and probably plays a key role in the fusion
of vesicles containing NKp44L.
The 3S motif of HIV-gp41 induces NKp44L translocation
to the cell surface
Next, we investigated whether the 3S peptide induces de novo
synthesis of NKp44L as well as its translocation to the plasma
membrane. High intracellular NKp44L expression was detected
by confocal microscopy in purified CD4
+ T cells in the absence of
3S-peptide stimulation. NKp44L molecules mainly colocalised
with the ER marker, GRP78 BiP, within unstimulated CD4
+ T
cells (Figure 3A). Similar results were obtained using the Hela cell
line (Supplementary Figure S1). The absence of NKp44L on the
surface of CD4
+ T cells in the absence of 3S-peptide is therefore
not due to the absence of NKp44L in the cytoplasm of
unstimulated cells but to the inability of these cells to translocate
NKp44L to their cell surface. Interestingly, the total level of
NKp44L expression remained similar in purified CD4
+ T cells,
without peptide stimulation or treated with the 3S peptide or
control peptide (Figure 3B). Concomitantly, at the cell surface,
NKp44L steadily and time-dependently increased in purified
CD4
+ T cells after 3S peptide incubation. NKp44L was absent
from the surface of untreated CD4
+ T cells and CD4
+ T treated
with control peptides (Figure 3C). Moreover, cycloheximide
treatment did not prevent NKp44L cell-surface induction on
primary CD4
+ T cells by the 3S peptide (Figure 3D). This findings
indicate that protein neosynthesis might not be necessary in this
signaling pathway and suggests that the 3S peptide directly induces
the translocation of pre-existing NKp44L molecules from the
cytoplasm to the surface of CD4
+ T cells.
The 3S motif of HIV-gp41 triggers Class I PI3K activation
We examined the signaling mediators upstream of NADPH
oxidase activation in further detail. For cytokine signaling, PI3K
indirectly activates Rac, one of the regulatory subunits of the
NADPH oxidase that leads to H2O2 production [26]. The role of
PI3K in NKp44L translocation was therefore investigated.
Purified CD4
+ T cells were incubated with 7 mM of PIP3, PIP2,
or carrier (neomycin) alone. As shown in Figure 4A, PIP3, but
neither PIP2 nor carrier alone, was sufficient to induce NKp44L
surface expression. Furthermore, similar levels of NKp44L were
observed on the surface of CD4
+ T cells after treatment with either
PIP3 or 3S peptide (Figure 4A). Of note, PIP3 did not induce
other tested ligands of activating NK receptor, including ULBP1-
3, MIC-A/B, CD112 or CD48 (Supplementary Figure S2). To
confirm the role of PIP3 production in cell-surface expression of
NKp44L, CD4
+ T cells were pre-incubated, separately, in the
presence of two PI3K inhibitors, wortmannin and Ly294,002.
These two inhibitors strongly decreased 3S peptide-mediated cell-
surface expression of NKp44L, in a dose-dependent manner
(Figure 4B). The inability of these two PI3K inhibitors to inhibit
H202-mediated NKp44L surface expression demonstrates that
NADPH activation occurs downstream of PI3K activation
(Figure 4C).
gC1qR is the receptor of the 3S motif of HIV-1 gp41
Finally, we searched for the receptor of the 3S motif of HIV-1
gp41 at the surface of CD4
+ T cells. Interestingly, a gp41 epitope,
closed to the 3S motif and located in residues 601–620, has been
reported to bind to C1q and to activate the complement pathway
[16]. In addition, the gp41 epitope located between residues 615–
635, which include the 3S motif, binds to soluble factor H, a
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the databases for a pleiotropic membrane receptor that is linked to
the complement cascade and that activates PI3K and/or NADPH
oxidase. Using the above criteria, we identified gC1qR, an atypical
receptor of the complement [27], as a potential receptor for the 3S
motif of HIV gp41.
To determine if gC1qR is the membrane partner of the 3S
motif, immunoprecipitation was performed with magnetic beads
covalently linked to the 3S peptide. Beads coupled to BSA were
used as a negative control. Both sets of beads were then separately
incubated with Jurkat CD4
+ T cells, in the presence of 3,39–
Dithiobis (sulfosuccinimidylpropionate) (DTTSSP), a chemical
cross-linker, to link the 3S peptide covalently with interacting
proteins. Cells were then lysed, and the interacting proteins eluted
from the beads. These proteins were analyzed by both SDS PAGE
and Western blotting (with a cocktail of two anti-gC1qR mAbs,
60.11 and 74.5.2). As Figure 5A shows, gC1qR was detected solely
in the presence of 3S peptide-coated beads. The specific
interaction between the 3S peptide and the gC1qR was confirmed
by ELISA. Addition of increasing concentrations of biotin-labeled
3S peptide showed strong and specific binding between gC1qR
and the 3S peptide (Figure 5B).
To confirm the role of gC1qR as receptor of the 3S motif of
HIV-1 gp41, CD4
+ T were pretreated with anti-gC1qR mAb
(74.5.2 or 60.11) or with the isotype-matched IgG and then
stained with FITC-labeled 3S peptide. As Figure 5C shows, the
presence of anti-gC1qR mAbs significantly inhibited the binding
of FITC-labeled 3S peptide to CD4
+ T cells. Similar results were
observed using biotin-labeled 3S (Supplementary Figure S3A).
Next, the ability of anti-gC1qR mAb to inhibit 3S peptide-
mediated induction of cell-surface NKp44L expression was tested
in purified CD4
+ T cells. Cells were pretreated with anti-gC1qR
mAb (74.5.2) and then incubated with the 3S peptide. As shown
in Figure 5D, NKp44L cell-surface expression was strongly
inhibited in the presence of anti-gC1qR mAb. Of note, another
clone of anti-gC1qR mAb (60.11) was also able to decrease 3S
mediated inductions of cell-surface expression of NKp44L but to
a lower extend to the 74.5.2 clone (Supplementary Figure S3B).
Similarly, anti-gC1qR mAb also inhibited NKp44L surface
expression on cells incubated with wild type HIV (NL4.3) for
4hr (Figure 5E).
After demonstrating that the 3S peptide is a new viral ligand of
gC1qR, we sought to determine if some endogenous ligands, such
as C1q and high molecular weight kininogen (HK), both of which
bind to gC1qR, also induce cell-surface expression of NKp44L.
Purified CD4
+ T cells were incubated for 4 h in the presence or
absence of C1q, HK, or 3S peptide, and then stained for
NKp44L surface expression. As Figure 5F shows, C1q, HK, and
the 3S peptide all induced high levels of NKp44L cell-surface
expression.
Discussion
In this report, we demonstrated that the gC1qR protein is the
receptor for the 3S motif of HIV-1 gp41 and that their interaction
induces NKp44L cell-surface expression on CD4
+ T cells. A
ubiquitous and highly anionic cellular 33-kDa protein, gC1qR was
initially identified and characterized as a receptor for the globular
heads of C1q (gC1q) [28]. Although it is located mainly in the
cytoplasm, particularly in mitochondria, its presence on the
surface of diverse human cells has been demonstrated unequiv-
ocally, both here and previously [29]. Indeed, we observed here
that the 3S peptide interacts with gC1qR expressed on the cell
surface of CD4
+ T cells. Although gC1qR does not have a
transmembrane domain, it is thought to transduce signals from the
cell surface through interactions with other membrane-bound
proteins. For example, the lateral association of gC1qR with b1-
integrin is required for C1q-mediated cell adhesion and spreading
[30]. Importantly, we showed that two major endogenous ligands
of gC1qR, C1q and HK, also induce cell surface expression of
NKp44L on CD4
+ T cells.
Induction of NKp44L surface expression could be relevant for
additional bacterial and viral infections. Indeed, gC1qR has been
reported to interact with and facilitate entry of numerous
microbial and parasitic pathogens, including for example Listeria
monocytogenes, Staphylococcus aureus as well as Plasmodium falciparum
[31,32,33]. More importantly, it is also utilized by some viruses,
including HCV, rubella virus, HSV and HTNV [27,34]. In
addition, gC1qR is expressed on several immune cells including
macrophages, dendritic and endothelial cells, B and T lympho-
cytes [27]. The pathogens listed earlier may induce NKp44L
surface expression on cells of the immune system mentioned
above. Here, we showed that gC1qR is also a receptor for the 3S
motif of the HIV-1 gp41 protein. However, in vitro the presence of
anti-gC1qR mAbs (74,5,2 or 60,11) had no or little impact on the
level of infection of purified CD4
+ T cells by both CCR5- and
CXCR4-tropic HIV strains (supplementary Figure S3C). This
strongly suggests that these anti-gC1qR mAbs lack the potential to
neutralize HIV-1 infection and that gC1qR is not required for
HIV-1 infection.
Virus binding to cell-surface receptors may trigger signaling
cascades in the host cell. Our examination of the signaling cascade
triggered by the 3S motif revealed that PI3K activation plays a
critical role in the 3S-mediated signaling that leads to NKp44L
translocation to the cell surface. We note that Braun et al
previously reported that the binding of internalin B of Listeria
monocytogenes to gC1qR activates PI3K [31]. In contrast to previous
reports of PI3K-mediated activation of Akt [35], Akt phosphor-
ylation was not detected here following 3S peptide stimulation
(data not shown). We traced the downstream signaling mediators
after 3S-induced PI3K activation. Activated PI3K produced PIP3,
which activated NADPH oxidase, probably by promoting GTP-
Figure 1. 3S peptide stimulation induces ROS production by NADPH oxidase. (A) Intracellular production of reactive oxygen species (ROS)
was measured with ROS-sensitive DCFH-DA. CD4
+ T cells were pre-incubated with 10 mM DCFH-DA. Samples were then incubated in the absence of
peptide (dotted line), in the presence of 20 mg/ml 3S peptide (thick solid line) or in the presence of 0.2 mg/ml PMA (thin solid line). DCFH-DA
fluorescence was then measured by luminometer every 3 min for 66 min. The curves shown are representative of experiments performed on purified
CD4
+ T cells from 5 individuals. (B) Induction of NKp44L expression by H2O2. CD4
+ T cells were stained with IgM isotype control (IgM), or CD4
+ T cells
that were unstimulated (NA), or that were stimulated with 5 mg/ml 3S peptide (3S) or with 100 mMH 2O2 were stained with anti-NKp44L mAb. (C)
NAC, an antioxidant, blocks NKp44L surface expression. CD4
+ T cells were pre-incubated without inhibitor (open bar) and with 1 mM NAC or with
10 mM NAC (black bars), and then stimulated with the 3S peptide. They were then stained with anti-NKp44L mAb. Unstimulated CD4
+ T cells stained
with anti-NKp44L mAb (NA) were used as negative controls. (D) DPI, a NADPH oxidase inhibitor, also blocks NKp44L surface expression. CD4
+ T cells
were pre-incubated without inhibitor (open bar) and with 2 mM DPI, or with 20 mM DPI (black bars), and then stimulated with the 3S peptide, before
staining with anti-NKp44L mAb. Unstimulated CD4
+ T cells stained with anti-NKp44L mAb (NA) were used as negative controls. For (B), (C) and (D)
(Left) The mean +/2 SD of NKp44L Mean fluorescence intensity (MFI) from experiments using CD4
+ T cells from 3 individuals are indicated. (Right)
One representative experiment is illustrated as FACS histograms.
doi:10.1371/journal.ppat.1000975.g001
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was first characterized in phagocytes was the regulation of the
activity of the NADPH oxidase complex, which produces reactive
oxygen species (ROS) including H2O2 [36,37]. We demonstrated
that H2O2, like the 3S peptide, was able to induce a high level of
NKp44L surface expression on CD4
+ T cells. Remarkably, H2O2
can also induce surface expression of some ligands for another NK
activating receptor, NKG2D, on airway epithelial cells; these
ligands include MICA/B and ULBP1-4. In addition, H2O2 did
not modify the intracellular levels of any of these ligands [38].
Similarly, the 3S peptide did not seem to affect intracellular levels
of NKp44L. This strongly suggests that H2O2 is a crucial mediator
in the translocation of activating NK ligands to the surface of
stressed cells that are flagged for destruction by NK-mediated lysis.
This hypothesis is supported by previous reports that H2O2 also
reduces HLA-A, -B, and -C molecules on epithelial cells, probably
favoring NK-mediated lysis [38]. Of note, H2O2 production by
the 3S peptide should inactivate PTEN, which would increase
PIP3 concentration and therefore H2O2 production. This suggests
a positive feedback loop to amplify NKp44L cell-surface
translocation. Similar signal amplification has previously been
described for EGF and PDGF stimulations [39].
We also demonstrated that in vitro the antioxidant NAC
prevented 3S-mediated NKp44L surface expression. Antioxidants
have previously been used in clinical trials for treatment of HIV-
infected individuals, but with contradictory results. Some have
failed to detect any significant beneficial effect on the CD4 cell
count of antioxidant supplementation added to HAART treat-
Figure 2. 3S peptide stimulation downregulates Rho activity via p190 RhoGAP A. (A) Purified CD4
+ T cells transfected with deficient p190
RhoGAP A (bold line) or wild-type p190 RhoGAP A (dotted line) were stained with anti-NKp44L antibodies. CD4
+ T cells stained with IgM isotype
control (light gray) were used as the negative control. (B) Rho activity was measured in lysate of CD4
+ T cells incubated with 5 mg/ml 3S peptide for
various lengths of time ranging from 1 to 60 min. (C) Western blot using lysate of CD4+ T cells pre-incubated in absence of siRNA (Lane 1) or with
control siRNA (Lane 2) or with siRNA against TC10 (Lane 3 & 4). Both Tubulin (top panel) and TC10 (bottom panel) were monitored. (D) TC10 siRNA
inhibits NKp44L cell-surface expression. Unstimulated CD4
+ T cells stained with IgM isotype control (light gray) or with anti-NKp44L mAb (bold line)
were used as negative controls. CD4
+ T cells were pre-incubated without siRNA (dark gray), with 1 mM control siRNA (thin solid line), 1 mM of either
siRNA against TC10 (dotted lines) before stimulation with the 5 mg/ml 3S peptide. Samples were then stained with anti-NKp44L mAb.
doi:10.1371/journal.ppat.1000975.g002
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PLoS Pathogens | www.plospathogens.org 6 July 2010 | Volume 6 | Issue 7 | e1000975Figure 3. The 3S peptide induces translocation of NKp44L to the cell surface. (A) NKp44L intracellular localization. CD4
+ T cells were
permeabilized and stained for NKp44L (red) and the golgi marker, giantin (green) or the ER marker, GRP78 BiP (green). Nuclei were stained using DAPI
(blue). (B) & (C) Kinetic study of total and surface NKp44L expression. CD4
+ T cells were incubated in absence of peptide (circle), in presence of the 3S
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responses [40]. In contrast, other in vivo studies have shown that
antioxidant supplementation of HIV-infected individuals under
HAART improved their CD4
+ cell count compared with placebo-
treated patients [41]. The discrepancies between these results may
be due to the type and dose of antioxidant used, as well as to
characteristics of the patients.
In the present study, we also showed that stimulation by the 3S
peptide activates the p190 RhoGAP-A protein. A previous report
showed that Rac-dependent ROS production leads to down-
regulation of RhoA through oxidative inactivation of low-
molecular-weight protein tyrosine phosphatase and the subsequent
activation of p190 RhoGAP-A [22]. In line with that study, our
data demonstrated that 3S peptide stimulation promotes the
inactive (GDP-bound) form of RhoA. It probably inactivates other
Rho family GTPases, notably RhoB, RhoC and TC10, which
have all been shown to be inactivated by p190 RhoGAP-A
[23,24]. We note that TC10, a Rho family GTPase mainly
localized on vesicular structures, plays a significant role in the
exocytosis of GLUT4 and other proteins [42]. More recently,
Kawase et al. [24] suggested that TC10 may be implicated in three
separate steps of exocytosis: loading cargo into secretory vesicles,
tethering vesicles to the plasma membrane, and triggering their
fusion. Here, we showed that TC10 was necessary for the 3S
peptide to induce the translocation of NKp44L to the cell surface.
Of note, 3S peptide inactivation of the above Rho family GTPases
might, as well as inducing NKp44L surface expression, affect
additional signaling pathways and lead to surface expression of
other membranes proteins. Indeed, the picture that is emerging
today shows that Rho family GTPases transduce signals from
pattern recognition receptors and from receptors of antigens,
chemokines, and cytokines, as well as adhesion molecules and they
function as focal points for crosstalk between different signaling
pathways [43].
We propose the following model for the translocation of
NKp44L to the plasma membrane after stimulation by the 3S
peptide (Figure 6): 1) The 3S motif of HIV-gp41 interacts with
gC1qR, its specific receptor; 2) this interaction activates PI3K; 3)
activated PI3K promotes the activation of the NADPH-oxidase; 4)
activated NADPH-oxidase promotes p190 RhoGAP-A activity;
and 5) activated p190 RhoGAP-A then induces GTP hydrolysis by
Rho-A and TC10, which are implicated in exocytosis. This
signaling cascade is similar to that previously described for insulin-
induced GLUT4 translocation. GLUT4 surface expression is also
dependent on H2O2 production [44], as well as PI3K [45], and
TC10 activation [42].
As we showed previously, the induction of NKp44L surface
expression on uninfected bystander cells by the 3S motif renders
them highly sensitive to NK lysis, a phenomenon that may lead to
the CD4 depletion observed during HIV-1 infection [8,11].
Interfering with NKp44L expression on the surface of CD4
+ T
cells should therefore be beneficial for HIV-1 infected individuals,
by preventing CD4 depletion. Blocking the interaction between
the 3S motif and its receptor with gC1qR antagonists should
inhibit NKp44L surface expression on CD4
+ T cells. Moreover,
we note that HCV is another pathogen that employs gC1qR to
subvert the immune response by inhibiting T cell activation and
proliferation [46]. Before gC1qR antagonists can be used to treat
HCV or HIV-1 infected individuals, suitable animal models are
needed to investigate the in vivo effect of gC1qR inhibition in both
HCV and HIV-1 infection. Alternatively, HIV-1 infected
individuals might be vaccinated with the 3S peptide. A macaque
model showed the efficacy of therapeutic immunization with the
3S motif of HIV gp41 against CD4 depletion [15].
Materials and Methods
CD4
+ T cell purification
Leukocytes from whole-blood samples from healthy donors
were obtained by buffy coat centrifugation from the hospital blood
bank (Ho ˆpital Pitie ´-Salpe ˆtrie `re, Paris, France), after approval by
the local ethics committee ‘‘Etablissement Franc ¸ais du sang’’.
Written consent from each individual was not required, as blood
samples were obtained from healthy anonymous donors. CD4
+ T
cells were purified with CD4 magnetic microbeads (Miltenyi).
Flow cytometric analysis demonstrated a purity of .95% CD4
+ T
cells. Purified CD4
+ T cells were incubated for 3 days with 1 mg/
ml PHA-L (Murex) in RPMI-1640 medium supplemented with
10% FCS and then cultured with 100 IU/ml Proleukin 2
(Chiron). The human CD4
+ T lymphoma Jurkat cell line and
the human promonocytic U2 cell line, were both grown in RPMI-
1640 medium containing 10% FCS at 37uC and 5% CO2. The
U2 cell line, which is derived from the promonocytic U937 cell
line, was used as it is sensitive to 3S-mediated NKp44L surface
induction.
Reagents
Anti-NKp44L mAb (IgM; #7.1) was previously described [8].
Purified unconjugated and Biotin- or FITC-conjugated 3S peptide
from HIV-1 gp41 (NH2-PWNASWSNKSLDDIW-COOH) as
well as scramble peptide (NH2-WNWDSKILSDPAWNS-
COOH) were purchased from Covalabs (Villeurbanne, France).
Complement component C1q (C1q), dibenziodolium chloride
(DPI), LY 294,002 hydrochloride, wortmannin, hydrogen perox-
ide 30% solution, and imidazole were all purchased from SIGMA.
Native human high molecular weight kininogen (HK) was
purchased from AbD Serotec, PIP3 and PIP2 from TEBU
Biosciences, anti-gC1qR (74.5.2 and 60.11), anti-TC10 (T304)
and anti GRP78 BiP mAbs from Abcam.
2D PAGE and protein identification
For each sample, approximately 2610
7 U2 cells were lysed with
IEF buffer (7 M urea, 2 M thiourea, 1% CHAPS, 10%
isopropanol, 10% isobutanol, 100 mM DTT, 0.5% SB 3–10,
0.2% Bio-Lyte, and 5% triton 6100). Proteins were separated by
2D PAGE. Briefly, protein lysates were mixed with IEF buffer
supplemented with 1% IPG pH 3–7 buffer (GE Healthcare),
12 mL/ml Destreak reagent (GE Healthcare) plus bromophenol
blue. Samples were added to 18 cm 3–10 NL strips (GE
Healthcare) and treated as previously described [47]. SDS-Page
was performed on 10% polyacrylamide, and gels were either
stained with Imperial Protein Stain (Pierce) or with the PlusOne
peptide (square) or scramble peptide (peptide 1) (triangle) for various length of time (ranging from 0 to 6hrs). Samples were either (B) permeabilized
and stained for total NKp44L or (C) stained for surface NKp44L. (D) Cycloheximide does not impede NKp44L surface expression. (Left) CD4
+ T cells
were pre-incubated without inhibitor (open bar) and with 100 mM Cycloheximide (black bars), and then stimulated with the 3S peptide. They were
then stained with anti-NKp44L mAb. Unstimulated CD4
+ T cells stained IgM isotype (IgM) or with anti-NKp44L mAb (NA) were used as negative
controls. Means +/2 SD of NKp44L MFI from 3 experiments using CD4
+ T cells from 3 individuals are illustrated. (Right) One representative
experiment is illustrated as FACS histograms.
doi:10.1371/journal.ppat.1000975.g003
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PLoS Pathogens | www.plospathogens.org 8 July 2010 | Volume 6 | Issue 7 | e1000975Figure 4. The 3S peptide activates the PI3K. (A) PIP3 induces cell-surface expression of NKp44L. CD4
+ T cells were stained with IgM isotype
control (IgM) or CD4
+ T cells without stimulation (NA), stimulated with the 5 mg/ml 3S peptide (3S), or 7 mM carrier alone; 7 mM PIP2, or 7 mM PIP3
were then stained with anti-NKp44L mAb. (B) Inhibitors of PI3K block cell-surface expression of NKp44L. CD4
+ T cells pre-incubated in the absence of
inhibitor (Open bar), with 2 or 20 mM Ly294,002 (Black bars), or with 10 or 100 nM wortmannin (Hatched bars) before stimulation with 5 mg/mL 3S
peptide were stained with anti-NKp44L mAb. Unstimulated CD4
+ T cells stained with anti-NKp44L mAb (NA) were used as negative controls. (C)
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turer’s instructions. Image Master 2D 6.0 software (GE Health-
care) was used to identify proteins significantly modulated from
three separate set of experiments. Imperial protein dye was
removed from gel pieces with 25 mM ammonium bicarbonate
(AMBIC) in 50% ethanol. Gel pieces were dried in acetonitrile
(ACN) and then digested with trypsin (PROMEGA). Peptides
were extracted twice in TFA 5%, ACN 60%. The combined
extracts were dried and resuspended in 0.1% TFA, 50% ACN.
Samples were then analyzed by Maldi-ToF (Autoflex by Bruker).
Measurement of the intracellular H2O2 concentration
Purified CD4
+ T cells were pre-incubated with 10 mM DCFH-
DA (2979 –dichlorofluorescein diacetate) in PBS (without Ca
2+ et
Mg
2+) and then incubated in the presence or absence of 20 mg/ml
3S peptide or with 0.2 mg/ml PMA as the positive control.
Fluorescence readings were performed every 3 min with a
microplate reader (Flexstation 3, Molecular Devices).
p190 RhoGAP A activity
Purified CD4
+ T cells were transfected by p190 RhoGAP A
wild type (pWT) or RhoGAP A dominant negative (pDN)
plasmids, a generous gift from Dr K. Burridge (University of
North Carolina, USA), with the Human T cell nucleofector kit
(AMAXA) according to the manufacturer’s instructions. p190Rho-
GAP-GFP and p190RhoGAPR1283A-GFP plasmids have been
previously described [48]. Transfection efficiency was verified by
flow cytometry using GFP fluorescence.
Rho activity assay
Purified CD4
+ T cells were incubated in the presence or
absence of 5mg/ml 3S peptide for various lengths of time, washed
with ice-cold PBS, and then rapidly lysed. For each sample, Rho
activity was measured from 12.5 mg total lysate with the G-LISA
luminometry-based assay (Tebu-Bio), according to the manufac-
turer’s instructions.
TC10 knock-down
Purified CD4
+ T cells were resuspended at 2610
6 cells/ml in
Accell siRNA delivery media (Dharmacon) supplemented with 100
unit/ml Proleukin 2. Cells were incubated for 72 h with 1 mM
siRNA control or with 1 mM Accell siRNA against TC10
(Dharmacon). Two separate siRNAs against TC10 were used
independently (59-CUACUGACCUUGAUGGGUU 39;5 9-
GCAUCAGAUAAUGGUGUUA -39). Samples were then incu-
bated in the presence or absence of 5 mg/ml 3S peptide before
NKp44L staining by flow cytometry. Silencing efficiency of the
different siRNAs was first monitored by western blot using anti-
TC10 mAb.
Fluorescence microscopy
CD4
+ T cells were fixed with 4% paraformaldehyde (PFA)
before permeabilisation using 0.1% Triton. Samples were then
stained using 1ug anti-NKp44L mAb and 0.75 mg Texas Red
conjugated anti mouse IgM mAb. For giantin staining, cells were
then incubated with 1/1000 diluted anti giantin mAb and 2 mg
diluted Alexa 488 conjugated anti Rabbit IgG. For GRP78 BiP
staining, cells were then incubated with 1/1000 diluted anti
GRP78 BiP and 2 mg diluted Alexa 488 conjugated anti Rabbit
IgG. For TC10 staining, cells were then incubated with 1/100
diluted anti TC10 mAb and 2 mg diluted Alexa 488 conjugated
anti Rabbit IgG. Following staining, samples were mounted using
ProLong Gold (Invitrogen).
Flow cytometry
FACS analysis was performed on purified CD4
+ T cells.
Isotype-matched immunoglobulin served as negative controls. For
NKp44L surface staining, samples were incubated with 2 mg anti
NKp44L antibodies for 1 h at 4uC then incubated in 100 mLo f
1:100 diluted PE anti mouse IgM antibodies (Pharmingen) and
CD4-APC antibodies (Beckman Coulter). P190 transfected were
stained using only APC anti mouse IgM antibodies (Pharmingen).
For total NKp44L level, cells were fixed using BD cellFix solution
(BD Biosciences) and permeabilised using 0.5% BSA, 0.1%
saponine. Cells were stained using 2 mg purified anti-NKp44L
antibodies and 1:100 diluted PE anti mouse IgM antibodies
(Pharmingen). At least 10000 events in the population of interest
were detected on a FACScalibur (BD Biosciences). Results were
analysed with cellQuest software.
Delivery of PIP (phospho-inositol) derivatives
PIP derivatives were delivered as previously described [49].
Briefly, solutions containing 250 mM PIP3 or PIP2 in the presence
of 250 mM carrier in RPMI medium without serum were freshly
prepared in HEPES buffer and then sonicated. Carrier, PIP3, or
PIP2 mixtures were added for 4 h to purified CD4
+ T cells at a
final concentration of 7 mM.
Production, detection, and immunoprecipitation of
gC1qR
Recombinant gC1qR protein was purified from E. coli
transformed with the pET28a-5 plasmid encoding for gC1qR, a
kind gift from E. Gouin and P. Cossart (Institut Pasteur, Paris,
France) [31]. Briefly, transformed E. coli was incubated with 1 mM
IPTG for 3 h, and then lysed. The recombinant gC1qR was
purified with the TALON dynabeads (Invitrogen), according to
the manufacturer’s instructions, and eluted in buffer containing
150 mM imidazole. The interaction between the 3S peptide and
gC1qR was determined with ELISA after coating with 0.5mg
gC1qR, or with BSA as control.
For immunoprecipitation, magnetic beads were coated with
25 mg of 3S peptide, or BSA, as control, per mg of beads,
according to the manufacturer’s instructions (Ademtech). For each
sample, approximately 40610
6 cells were mixed with 2 mg of
coated beads for 1 h at 4uC, in the presence of 2 mM DTSSP.
After incubation, cells were lysed with 1% SDS for 30 min. The
magnetic beads were then collected and washed several times with
1 M KCl, followed by 0.1 M NA2CO3 pH11 and by hypotonic
buffer (10 mM Hepes, 10 mM KCl, 1.5 M MgCl2) in the presence
of protease inhibitor cocktail, as previously described [50]. Purified
proteins were eluted, subjected to SDS-PAGE, and then analyzed
by Western blot, in the presence of 1.5 mg/ml anti-gC1qR (74.5.2
mAb) and 1 mg/ml anti-gC1qR (60,11 mAb) mAbs. After
extensive washing, membranes were analyzed with the Etan Dige
Imager.
Inhibitors of PI3K do not inhibit cell-surface expression of NKp44L following H2O2 treatment. CD4
+ T cells pre-incubated in the absence of inhibitor
(Open bar), with 20 mM Ly294,002 (Black bars), or with 100 nM wortmannin (Hatched bars), before stimulation with 100 mMH 2O2 were stained with
anti-NKp44L mAb. Unstimulated CD4
+ T cells stained with anti-NKp44L mAb (NA) were used as negative controls. (Left) The mean +/2 SD of NKp44L
MFI from 3 experiments using CD4
+ T cells from 3 individuals is illustrated. (Right) One representative experiment is illustrated as FACS histograms.
doi:10.1371/journal.ppat.1000975.g004
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PLoS Pathogens | www.plospathogens.org 10 July 2010 | Volume 6 | Issue 7 | e1000975Figure 5. gC1qR is the receptor for the 3S motif of HIV-1 gp41. (A) Immunoprecipitation of gC1qR. Magnetic beads were coated with either
BSA or 3S peptide. Coated beads were used to immunoprecipitate the receptor of the 3S motif. Purified proteins were analyzed by Western blot with
anti-gC1qR mAbs (74.5.2 and 60.11). Lane 1: Eluate using BSA coated beads; Lane 2: Eluate using 3S coated beads. (B) Interaction of gC1qR with 3S
peptide by Elisa. Microplate wells were coated with gC1qR or BSA and incubated with increasing concentrations of biotin-conjugated 3S peptide.
Biotin was detected with HRP-conjugated streptavidin. (C) Inhibition of 3S interaction by anti-gC1qR mAbs. CD4
+ T cells were pretreated with 10 mg/
ml anti-gC1qR mAb (74.5.2 or 60.11) or IgG1 isotype control, before incubation with 16mg FITC-conjugated 3S peptide. CD4
+ T cells incubated with
16mg FITC-conjugated scramble peptide (peptide 1) was used as negative control. (D, E) Inhibition of 3S-dependent and HIV-mediated NKp44L
stimulation by anti-gC1qR mAbs. CD4
+ T cells pre-incubated in the absence of antibodies (dark gray), with 10 ug/ml mouse IgG1 (thin solid line), or
10 mg/ml anti-gC1qR 74.5.2 clone (dotted line) before stimulation during 4 hr with (D) 5 mg/mL 3S peptide or (E) wild type HIV virus (NL4,3), were
stained with anti-NKp44L mAb. As controls, unstimulated CD4
+ T cells were stained with IgM isotype control (light gray) or anti-NKp44L antibodies
(bold line). (F) Induction of NKp44L surface expression by the natural ligand of gC1qR. CD4
+ T cells, either unstimulated (NA), or stimulated with 5 mg/
ml 3S peptide (3S), 10 mg/ml C1q (C1q) or 10 mg/ml HK (HK), were stained with anti-NKp44L mAb. As control, CD4
+ T cells were stained with IgM
isotype control (IgM). (Left) The mean +/2 SD of NKp44L MFI from 3 experiments using CD4
+ T cells from 3 individuals is illustrated. (Right) One
representative experiment is illustrated as FACS histograms.
doi:10.1371/journal.ppat.1000975.g005
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Supporting Information
Figure S1 NKp44L intracellular localization. Hela cells were
permeabilised and stained for NKp44L (red) and the golgi marker,
giantin (green) or the ER marker, calnexin (green). Nuclei were
stained using DAPI (blue).
Found at: doi:10.1371/journal.ppat.1000975.s001 (1.00 MB TIF)
Figure S2 PIP3 or H2O2 stimulation does not affect expression
of other activating NK ligands including NKG2D ligands. CD4
+
T cells were stained with isotype control (IgM or IgG2) or CD4
+ T
cells without stimulation (NA), stimulated with the 5 mg/ml 3S
peptide (3S), or 7 mM PIP2, or 7 mM PIP3 or 100 mMH 2O2 were
Figure 6. Model of 3S mediated NKp44L translocation on CD4
+ T cells. 1) The 3S motif of HIV-gp41 binds to its receptor, gC1qR; 2) upon
binding gC1qR activates PI3K; 3) activated PI3K indirectly induces H2O2 production by NADPH-oxidase; 4) H2O2 produced promotes p190 RhoGAP-A
activity;and5)activatedp190 RhoGAP-A theninducesGTP hydrolysisbyRho-AandTC10,whichareimplicatedinexocytosisofNKp44Lbearing vesicles.
doi:10.1371/journal.ppat.1000975.g006
Table 2. Accession numbers.
Name Accession number (Swissprot) Entry name
TC10 P17081 RHOQ_HUMAN
P190RhoGAP Q9NRY4 GRLF1_HUMAN
gC1qR Q07021 C1QBP_HUMAN
C1q (heterotrimer
made of)
P02745 C1QA_HUMAN
P02747 C1QC_HUMAN
P02746 C1QB_HUMAN
HK P01042 KNG1_HUMAN
doi:10.1371/journal.ppat.1000975.t002
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mAb, (C) anti-ULPB1-3 mAbs, (D) CD48 and HLA A, B, C mAbs
or (E) CD112 and CD62L mAbs.
Found at: doi:10.1371/journal.ppat.1000975.s002 (0.86 MB TIF)
Figure S3 Anti-gC1qR mAbs inhibit 3S peptide binding and
subsequent NKp44L induction. (A) Inhibition of 3S interaction by
anti-gC1qR mAbs. CD4
+ T cells were pretreated with 10 mg/ml
anti-gC1qR mAb (74.5.2 or 60.11 clones) or IgG1 isotype control,
before incubation with biotin-conjugated 3S peptide. Peptide was
revealed using PE conjugated strepatividin. (B) Inhibition of 3S-
dependent NKp44L stimulation by anti-gC1qR mAbs. CD4
+ T
cells pre-incubated in the absence of antibodies (dark gray), with
10 ug/ml mouse IgG1 (thin solid line), or 10 mg/ml anti-gC1qR
74.5.2 clone or 60.11 clone (dotted line) before stimulation with
5 mg/mL 3S peptide, were stained with anti-NKp44L mAb. As
controls, unstimulated CD4
+ T cells were stained with IgM isotype
control (light gray) or anti-NKp44L antibodies (bold line). (C)
Anti-gC1qR mAbs do not prevent CD4
+ T cells infection. CD4
+ T
cells were pretreated with 10 mg/ml anti-gC1qR mAb (74.5.2 or
60.11 clones) or IgG1 isotype control or in absence of mAb.
Samples were then infected with wild type HIV virus (NL4.3).
After 24hrs (left) or 48hrs infection (right), level of infection was
monitored by ELISA by dosing p24 antigen.
Found at: doi:10.1371/journal.ppat.1000975.s003 (0.58 MB TIF)
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